PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1907343
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1907343
The United States pet food market was valued at USD 77.01 billion in 2025 and estimated to grow from USD 82.08 billion in 2026 to reach USD 112.86 billion by 2031, at a CAGR of 6.59% during the forecast period (2026-2031).

Rising disposable incomes and the continued humanization of pets drive demand for premium and functional formulations across urban and suburban households. Fresh and minimally processed foods are gaining traction as owners equate diet quality with preventive healthcare, prompting manufacturers to invest in cold-chain logistics and human-grade production lines. E-commerce adoption accelerates the adoption of subscription services that lock in repeat purchases and facilitate personalized diet plans. At the same time, sustained R&D around gut health additives and alternative proteins positions ingredient suppliers for incremental growth through 2030.
The shift toward human-grade pet food formulations represents a fundamental recalibration of consumer expectations, with pet owners increasingly viewing nutrition as a form of preventive healthcare rather than merely basic sustenance. This trend drives margin expansion across the value chain, as human-grade products command price premiums of 40-60% over conventional kibble formulations[1]. The regulatory framework surrounding human-grade claims has tightened significantly, with AAFCO (Association of American Feed Control Officials) establishing stricter guidelines for ingredient sourcing and processing standards that mirror human food safety protocols. The trend particularly benefits smaller, specialized brands that can navigate regulatory compliance more efficiently than large-scale manufacturers, who are often constrained by existing infrastructure investments.
Functional ingredient integration transforms pet food from basic nutrition to targeted health intervention, with probiotics, prebiotics, and omega-3 fatty acids becoming standard inclusions rather than premium add-ons. Research on the gut-brain axis in companion animals mirrors human nutrition science, creating opportunities for cross-pollination between ingredient suppliers serving both markets. Regulatory influence from the FDA's Center for Veterinary Medicine ensures ingredient safety while allowing health claims that support premium positioning. This trend particularly benefits ingredient suppliers with dual human-pet portfolios, creating economies of scale and shared R&D investments across market segments.
Protein cost volatility creates margin compression, forcing manufacturers to balance ingredient quality with pricing competitiveness, particularly for premium products that emphasize high meat content. Chicken prices increased 23% year-over-year in 2024, while beef costs rose 18%, creating significant input cost pressures for manufacturers heavily reliant on animal proteins . Supply chain diversification becomes increasingly critical as companies seek alternative protein sources, including insect-based and plant-based formulations, that offer both cost stability and sustainability benefits. The constraint particularly impacts smaller manufacturers with limited purchasing power and supply chain flexibility compared to large-scale producers with global sourcing capabilities and long-term supplier contracts.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Food products maintain a dominant market position, with a 68.35% share in 2025, encompassing both traditional dry and wet formulations that serve as the foundation for the market. his accelerated growth is primarily driven by the increasing prevalence of health issues in pets, particularly pet obesity and dental problems, coupled with growing awareness among pet owners about preventive healthcare. The segment's growth is supported by the rising demand for premium and specialized pet food ingredients, including grain-free and organic options. Major manufacturers are continuously expanding their production capabilities and introducing innovative products to meet the evolving nutritional requirements of pets.
Pet veterinary diets are emerging as the fastest-growing segment, with an 7.62% CAGR through 2031, reflecting the medicalization of pet nutrition as veterinarians increasingly prescribe therapeutic formulations for specific health conditions. The segment's expansion is further supported by veterinarians' increasing recommendations for specialized diets to manage various health conditions. The market is witnessing a significant shift towards customized veterinary diets, with manufacturers developing specialized formulations for specific health conditions such as diabetes, digestive sensitivity, and urinary tract diseases. The rise of e-commerce channels has also contributed to the segment's growth by improving accessibility to these specialized products.
The United States Pet Food Market Report is Segmented by Pet Food Product (Food, Pet Nutraceuticals/Supplements, Pet Treats, and More), by Pets (Cats, Dogs, and More), and by Distribution Channel (Convenience Stores, Online Channel, Specialty Stores, Supermarkets/Hypermarkets, and More). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Metric Tons).